27.11.2014 Views

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

A Guide to Primary Care of People with HIV/AIDS - Canadian Public ...

SHOW MORE
SHOW LESS

You also want an ePaper? Increase the reach of your titles

YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.

A <strong>Guide</strong> <strong>to</strong> <strong>Primary</strong> <strong>Care</strong> <strong>of</strong> <strong>People</strong> <strong>with</strong> <strong>HIV</strong>/<strong>AIDS</strong><br />

Chapter 12: Family Planning and Pregnancy<br />

12<br />

intercurrent STDs should be treated, and attempts <strong>to</strong><br />

conceive should be well timed around ovulation <strong>to</strong> avoid<br />

unnecessary exposures during periods <strong>of</strong> decreased<br />

fertility. The American College <strong>of</strong> Obstetricians and<br />

Gynecologists has recently endorsed the use <strong>of</strong><br />

reproductive technology in <strong>HIV</strong>-infected patients (ACOG,<br />

2004). Which patients should be <strong>of</strong>fered assisted<br />

reproduction and what the optimal methods are <strong>of</strong><br />

decreasing heterosexual and perinatal <strong>HIV</strong> transmission<br />

must be determined.<br />

When should pregnancy testing be done?<br />

Since most pregnancies are unplanned, the diagnosis <strong>of</strong><br />

pregnancy frequently occurs late in the first trimester,<br />

when organogenesis is nearly complete. In order <strong>to</strong><br />

make the diagnosis earlier, pregnancy tests should be<br />

done when sexually active women have:<br />

• Late or missed menses (unless she is using Norplant<br />

or Depo-Provera)<br />

• Irregular bleeding (unless she is using Norplant or<br />

Depo-Provera)<br />

• New onset <strong>of</strong> irregular bleeding after prolonged<br />

amenorrhea <strong>with</strong> Norplant/Depo-Provera<br />

• New onset <strong>of</strong> pelvic pain<br />

• Enlarged uterus or adnexal mass on exam<br />

In addition, women <strong>with</strong> the potential <strong>of</strong> becoming<br />

pregnant should be tested before starting potentially<br />

tera<strong>to</strong>genic therapies such as efavirenz (EFV), which<br />

is the only antiretroviral drug that is contraindicated<br />

in pregnancy. Patients should be alerted <strong>to</strong> potential<br />

tera<strong>to</strong>genic effects on the fetus, and suitable<br />

contraception should be prescribed.<br />

What contraceptive methods are recommended<br />

for women <strong>with</strong> <strong>HIV</strong> who do not want <strong>to</strong><br />

become pregnant?<br />

Condoms are the most common contraceptive method<br />

used by women living <strong>with</strong> <strong>HIV</strong>. Condoms, consistently<br />

used, have the added advantage <strong>of</strong> providing protection<br />

against STDs, including potential reinfection <strong>with</strong> <strong>HIV</strong>.<br />

This benefit should be emphasized when contraceptive<br />

advice is given <strong>to</strong> an <strong>HIV</strong>-positive or at-risk woman even<br />

if she is not seeking or does not need contraception but<br />

is sexually active.<br />

Hormonal methods <strong>of</strong> contraception are also frequently<br />

used (delivered orally, by injection, or by skin patch).<br />

However, there are many important drug interactions<br />

between hormonal contraceptives and drugs used <strong>to</strong><br />

treat <strong>HIV</strong> infection and <strong>HIV</strong>-related complications (see<br />

next question).<br />

What are the most common drug interactions<br />

between oral contraceptives and drugs used in<br />

<strong>HIV</strong> disease?<br />

Oral contraceptives significantly interact <strong>with</strong><br />

amprenavir/fosamprenavir (APV/FAPV), efavirenz (EFV),<br />

lopinavir (LPV), nelfinavir (NFV), nevirapine (NVP), and<br />

ri<strong>to</strong>navir (RTV); an additional method <strong>of</strong> contraception,<br />

such as condoms, is recommended. Similarly, other<br />

drugs commonly used by <strong>HIV</strong>-infected patients,<br />

including tetracycline, rifampin, oral anticoagulants,<br />

beta-blockers, and antidepressants interact <strong>with</strong><br />

oral contraceptives, and an additional means <strong>of</strong><br />

contraception is advisable. Indinavir and atazanavir do<br />

not appear <strong>to</strong> have an interaction.<br />

What contraceptive methods are not highly<br />

recommended for women <strong>with</strong> <strong>HIV</strong> who do not<br />

want <strong>to</strong> become pregnant?<br />

Spermicides: Generally, a spermicide should be<br />

used along <strong>with</strong> a barrier method <strong>to</strong> increase its<br />

effectiveness. However, in some studies nonoxynol-9<br />

(the active ingredient in spermicidal contraceptives)<br />

has been found <strong>to</strong> cause vaginal irritation and epithelial<br />

inflammation when used as the sole contraceptive<br />

method and on a regular and frequent basis. This may<br />

increase the risk <strong>of</strong> <strong>HIV</strong> transmission.<br />

Intrauterine Device: The intrauterine device (IUD) is<br />

not recommended for <strong>HIV</strong>-infected women. The IUD is<br />

associated <strong>with</strong> pelvic inflamma<strong>to</strong>ry disease and is also<br />

associated <strong>with</strong> increased menstrual flow. Some studies<br />

even suggest that this device is linked <strong>to</strong> increased<br />

susceptibility <strong>to</strong> <strong>HIV</strong> transmission.<br />

PREVENTING MOTHER-<br />

TO-CHILD TRANSMISSION<br />

(MTCT)<br />

Which are the current recommendations for<br />

<strong>HIV</strong> testing <strong>of</strong> pregnant women?<br />

Since prevention <strong>of</strong> vertical transmission (from mother<br />

<strong>to</strong> child) <strong>of</strong> <strong>HIV</strong> is so effective, identification <strong>of</strong> <strong>HIV</strong><br />

infection in all women who are pregnant is imperative.<br />

Therefore:<br />

• <strong>HIV</strong> testing should be a routine part <strong>of</strong> prenatal care<br />

for all women. The “opt out” method, in which <strong>HIV</strong><br />

testing is included in the routine bloodwork and<br />

pregnant women have <strong>to</strong> refuse the test, results in<br />

higher test rates and should be used.<br />

98<br />

U.S. Department <strong>of</strong> Health and Human Services, Health Resources and Services Administration, <strong>HIV</strong>/<strong>AIDS</strong> Bureau

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!